Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.
2.

The efficacy of catheters coated with minocycline and rifampin in the prevention of catheter-related bacteremia in cancer patients receiving high-dose interleukin-2.

Chemaly RF, Sharma PS, Youssef S, Gerber D, Hwu P, Hanmod SS, Jiang Y, Hachem RY, Raad II.

Int J Infect Dis. 2010 Jul;14(7):e548-52. doi: 10.1016/j.ijid.2009.08.007. Review.

3.

Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial.

Hanna H, Benjamin R, Chatzinikolaou I, Alakech B, Richardson D, Mansfield P, Dvorak T, Munsell MF, Darouiche R, Kantarjian H, Raad I.

J Clin Oncol. 2004 Aug 1;22(15):3163-71. Erratum in: J Clin Oncol. 2005 May 20;23(15):3652.

PMID:
15284269
4.

Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group.

Raad I, Darouiche R, Dupuis J, Abi-Said D, Gabrielli A, Hachem R, Wall M, Harris R, Jones J, Buzaid A, Robertson C, Shenaq S, Curling P, Burke T, Ericsson C.

Ann Intern Med. 1997 Aug 15;127(4):267-74.

PMID:
9265425
5.

Reduced intravascular catheter-related infection by routine use of antibiotic-bonded catheters in a surgical intensive care unit.

Kamal GD, Divishek D, Kumar GC, Porter BR, Tatman DJ, Adams JR.

Diagn Microbiol Infect Dis. 1998 Mar;30(3):145-52.

PMID:
9572020
6.

Totally implanted catheters to reduce catheter-related infections in patients receiving interleukin-2: a 2-year experience.

Escudier B, Lethiec JL, Angevin E, Andremont A, Cosset-Delaigue MF, Antoun S, Leclercq B, Nitenberg G.

Support Care Cancer. 1995 Sep;3(5):297-300.

PMID:
8520875
7.

[Infectious and non-infectious complications of tunneled central catheters in hematologic patients].

Albo López C, López Rodríguez D, Constenla Camba MI, Jimenéz Blanco A, Araujo LF, García-Medina J.

Sangre (Barc). 1999 Jun;44(3):176-81. Spanish.

PMID:
10481577
8.

Antibiotic-coated hemodialysis catheters for the prevention of vascular catheter-related infections: a prospective, randomized study.

Chatzinikolaou I, Finkel K, Hanna H, Boktour M, Foringer J, Ho T, Raad I.

Am J Med. 2003 Oct 1;115(5):352-7.

PMID:
14553869
9.

A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters.

Fraenkel D, Rickard C, Thomas P, Faoagali J, George N, Ware R.

Crit Care Med. 2006 Mar;34(3):668-75.

PMID:
16505651
10.

Reduced colonization and infection with miconazole-rifampicin modified central venous catheters: a randomized controlled clinical trial.

Yücel N, Lefering R, Maegele M, Max M, Rossaint R, Koch A, Schwarz R, Korenkov M, Beuth J, Bach A, Schierholz J, Pulverer G, Neugebauer EA.

J Antimicrob Chemother. 2004 Dec;54(6):1109-15.

11.

Benefits of minocycline and rifampin-impregnated central venous catheters. A prospective, randomized, double-blind, controlled, multicenter trial.

León C, Ruiz-Santana S, Rello J, de la Torre MV, Vallés J, Alvarez-Lerma F, Sierra R, Saavedra P, Alvarez-Salgado F; Cabaña Study Group..

Intensive Care Med. 2004 Oct;30(10):1891-9.

PMID:
15278273
12.
13.

Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections.

Raad I, Hanna HA, Alakech B, Chatzinikolaou I, Johnson MM, Tarrand J.

Ann Intern Med. 2004 Jan 6;140(1):18-25.

PMID:
14706968
14.

Antiseptic chamber-containing hub reduces central venous catheter-related infection: a prospective, randomized study.

León C, Alvarez-Lerma F, Ruiz-Santana S, González V, de la Torre MV, Sierra R, León M, Rodrigo JJ.

Crit Care Med. 2003 May;31(5):1318-24.

PMID:
12771597
15.

The use of rifampicin-miconazole-impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia.

Lorente L, Lecuona M, Ramos MJ, Jiménez A, Mora ML, Sierra A.

Clin Infect Dis. 2008 Nov 1;47(9):1171-5. doi: 10.1086/592253.

16.

Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: effect of mupirocin ointment.

Sesso R, Barbosa D, Leme IL, Sader H, Canziani ME, Manfredi S, Draibe S, Pignatari AC.

J Am Soc Nephrol. 1998 Jun;9(6):1085-92.

17.

A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates.

Garland JS, Alex CP, Mueller CD, Otten D, Shivpuri C, Harris MC, Naples M, Pellegrini J, Buck RK, McAuliffe TL, Goldmann DA, Maki DG.

Pediatrics. 2001 Jun;107(6):1431-6.

PMID:
11389271
18.

Antimicrobial durability and rare ultrastructural colonization of indwelling central catheters coated with minocycline and rifampin.

Raad II, Darouiche RO, Hachem R, Abi-Said D, Safar H, Darnule T, Mansouri M, Morck D.

Crit Care Med. 1998 Feb;26(2):219-24.

PMID:
9468157
19.

Prospective study of infections in indwelling central venous catheters using quantitative blood cultures.

Benezra D, Kiehn TE, Gold JW, Brown AE, Turnbull AD, Armstrong D.

Am J Med. 1988 Oct;85(4):495-8.

PMID:
3177396
20.

An attachable silver-impregnated cuff for prevention of infection with central venous catheters: a prospective randomized multicenter trial.

Maki DG, Cobb L, Garman JK, Shapiro JM, Ringer M, Helgerson RB.

Am J Med. 1988 Sep;85(3):307-14.

PMID:
3046351
Items per page

Supplemental Content

Support Center